DrugPatentWatch Database Preview
Provensis Company Profile
What is the competitive landscape for PROVENSIS, and when can generic versions of PROVENSIS drugs launch?
There are fourteen US patents protecting PROVENSIS drugs.
There are one hundred and sixty-nine patent family members on PROVENSIS drugs in thirty-nine countries.
Summary for Provensis
| International Patents: | 169 |
| US Patents: | 14 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Provensis
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | RX | Yes | Yes | 8,323,677 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | RX | Yes | Yes | 7,357,336 | ➤ Sign Up | ➤ Sign Up | ||||
| Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | RX | Yes | Yes | 7,604,185 | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | RX | Yes | Yes | 8,122,917 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Provensis
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | RE38919 | ➤ Sign Up |
| Provensis | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | RE40640 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Non-Orange Book US Patents for Provensis
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 8,048,439 | Therapeutic foam | ➤ Sign Up |
| 8,091,801 | Generation of therapeutic microfoam | ➤ Sign Up |
| 7,763,269 | Therapeutic foam | ➤ Sign Up |
| 9,545,378 | Aerosol valve | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Provensis Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 2269578 | ➤ Sign Up |
| African Intellectual Property Organization (OAPI) | 13287 | ➤ Sign Up |
| Canada | 2373939 | ➤ Sign Up |
| Taiwan | I230732 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.
